Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

CIMG Inc.

CIK: 15276132 Annual ReportsLatest: 2025-07-30

10-K / July 30, 2025

Revenue:$1,930,291
Income:-$8,555,388

10-K / June 14, 2024

Revenue:$3,348,831
Income:-$8,749,467

10-K / July 30, 2025

Company Summary – CIMG Inc.

Business Overview

  • Type: Public company incorporated in Nevada, listed on Nasdaq under ticker "IMG"
  • History: Originally known as NuZee, Inc., changed name and ticker in October 2024
  • Focus Transition: From specialty coffee and related technologies to expanding sales of maca-based health and wellness products in Asia

Core Business Activities

  • Product Development & Distribution:
    • Sourced, marketed, and sold maca-derived dietary supplements, functional foods, and beauty products
    • Focuses on high-quality, sustainably sourced maca products
  • Product Lines:
    • Maca Series: Includes Maca Peptide Coffee, Maca-Noni, Maca Wine, Maca Purified Powder
    • These contain maca green purification factors, emphasizing natural and clean composition
    • Main Markets: Asia (mainly China and Southeast Asia), with distribution via wholesale channels (grocery stores, convenience stores, vending machines)
    • Sales Channels: Both online and offline retail, with plans to expand into retail services and digital marketing

Market & Distribution

  • Key Markets: Hong Kong, China, other parts of Asia
  • Customers: Primarily wholesale distributors such as grocery stores, convenience stores, and vending machine operators
  • Distribution Rights: Exclusive rights to maca products produced by Jiangsu Kangduoyuan Beverage Co., Ltd.

Employees & Operations

  • Employees (as of September 30, 2024):
    • United States: 1 employee
    • Hong Kong: 4 employees
    • Mainland China: 12 employees
    • Total: 17 full-time employees
  • Office Locations:
    • Hong Kong: Room R2, FTY D, Kin Ga Industrial Building, Tuen Mun
    • U.S.: Florida (Delray Beach)
    • China: Beijing, with leased facilities expiring in December 2025

Financial Highlights

  • 2024 Revenue: ~$1.93 million
  • 2023 Revenue: ~$1.76 million
  • Change in Revenue: +9.80% (year-over-year)
  • Gross Margin (2024): 1.69% (improved from -10.71% in 2023)
  • Cost of Sales (2024): ~$1.90 million
  • Net Loss (2024): ~$8.97 million (slight increase from ~$8.75 million in 2023)
  • Assets & Capital:
    • Cash (as of September 30, 2024): ~$460,000
    • Stockholders’ equity (as of latest filings): Below Nasdaq minimum requirement (exact amount not specified)
    • Outstanding Shares (as of July 2, 2025): 36,397,418 shares

Notable Developments & Strategy

  • 2024 Focus:
    • Launch of health-oriented maca product series
    • Moving away from contract coffee packaging to focus on maca products
  • Distribution Rights:
    • Exclusive rights to maca products in Asia from Jiangsu Kangduoyuan Beverage Co., Ltd.
  • Growth Plans:
    • Expand product offerings
    • Catalyze geographic expansion, especially in Asia and potentially into North America and Europe
    • Strengthen brand awareness through digital marketing
    • Increase distribution channels, including retail and online platforms

Risks & Regulatory

  • Operations in China subject to extensive regulatory environment and risks related to data security, cybersecurity reviews, and government approvals
  • Company has experienced Nasdaq listing deficiencies due to low stock price and insufficient stockholders' equity
  • No dividends paid or planned; profits/revenue are reinvested for growth

Summary:
CIMG Inc. is transitioning from a coffee focus to a major player in maca-based health and wellness products, with exclusive distribution rights in Asia, a small but growing revenue base (~$1.93 million in 2024), and approximately 17 full-time employees. It operates offices in Hong Kong, China, and the U.S. and seeks growth via product expansion, geographic reach, and enhanced branding.